Basic Cardiovascular Sciences  /  GS06. Cardiac Metabolism in Health and Disease  /  Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure
Logo

American Heart Association

  109
  0

Final ID:

Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure

  • Shah, Svati  ( DUKE UNIV MEDICAL CENTER , Hillsborough , North Carolina , United States )
    • Author Disclosures:
    Svati Shah: DO have relevant financial relationships ; Research Funding (PI or named investigator):nference:Active (exists now) ; Other (please indicate in the box next to the company name):Unlicensed patent:Active (exists now) ; Research Funding (PI or named investigator):Verily, Inc.:Active (exists now) ; Research Funding (PI or named investigator):Lilly, Inc.:Past (completed) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

GS06. Cardiac Metabolism in Health and Disease

Tuesday, 07/23/2024 , 01:30PM - 02:45PM

General Session

More abstracts on this topic:
Locking and Unlocking Cardiac Maturation

Kelly Daniel

Targeting Cardiac Fatty Acid Oxidation to Treat HFpEF

Lopaschuk Gary

More abstracts from these authors:
Associations of Biomarkers with Epicardial Adipose Tissue Volume and Density in Cardiovascular Risk Assessment: Insights from the PROMISE Trial

Ashar Perisa, Hadzic Ibrahim, Kwee Lydia, Langenbach Marcel, Douglas Pamela, Shah Svati, Foldyna Borek

Multi-Omics for Disentangling Clinical Heterogeneity: Heart Failure as a Paradigm

Ho Jennifer, Shah Sanjiv, Shah Svati

You have to be authorized to contact abstract author. Please, Login
Not Available